课题基金 / 基金详情

CK21-003, Oregon Child Absenteeism due to Respiratory Disease Study - 3

CK21-003, Oregon Child Absenteeism due to Respiratory Disease Study - 3
CK21-003,俄勒冈州儿童因呼吸道疾病缺勤研究 - 3
批准号:
10833456
负责人:
JONATHAN L TEMTE
金额:
$130.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2024-08-31

项目摘要

项目成果

JONATHAN L TEMTE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT Background: Influenza (Flu) is common in children and a leading cause of school absenteeism. SARS-CoV-2 (SARS) has emerged as a significant pathogen, but the role of children in post-peak and post-pandemic transmission needs to be defined. Both viruses cause substantial morbidity, mortality and economic costs. As Flu is efficiently spread within school settings, rates of absenteeism have been proposed as an early warning system. Accordingly, we created and tested a simple modification of an existing electronic school information system (ESIS) to automatically report cause-specific absenteeism. We found a significant association between cause-specific K-12 school absenteeism and prevalence of medically-attended Flu in our six-year study, allowing for Flu monitoring and early warning for acceleration in community activity. We have also documented substantial within-household Flu transmission. Similar studies— using our established and effective methods—are needed for the newly emerged coronavirus, SARS. Program Goal: The goals of ORCHARDS-3 are to expand the absenteeism system to evaluate the effectiveness for SARS monitoring and to describe the level of within-household transmission of Flu and SARS from index cases who are school-aged children. Methods: We will use parental reporting of symptoms into a telephonic absence reporting system and an algorithm within the ESIS for daily absenteeism assessment. We will actively recruit ≥300 children absent due to Flu-like illness (ILI) or COVID-like illness (CLI) from the Oregon School District, Dane County, WI, in each of three years. Home visits will be used to collect detailed demographic, household, epidemiologic and symptom data, and nasal and NP/OP specimens for testing. Nasal specimens will be tested for Flu/SARS using SOFIA-2 FIA rapid testing. NP/OP specimens will be transported to the Wisconsin State Laboratory of Hygiene for Flu/SARS rRT-PCR testing and for the presence of other respiratory viruses using a Luminex Multiplex PCR platform. We will recruit ≥240 households/yr with ill children for transmission assessment. All household members will self-collect nasal specimens on day 0, 7 and 14 for Flu/SARS rRT-PCR and provide detailed illness data. Temporal patterns of absenteeism due to ILI and CLI will be compared to virological surveillance within the surrounding community. Rates of within-home transmission of Flu and SARS will be calculated. Significance: Transmission and amplification within schools, followed by transmission from children to other household members likely expands outbreaks. Cause-specific absenteeism monitoring of Flu and SARS may provide early detection in a community allowing for use of countermeasures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CK21-003, Oregon Child Absenteeism due to Respiratory Disease Study - 3
  • 批准号:
    10320583
  • 项目类别:
  • 资助金额:
    $96.74万
  • 财政年份:
    2021
  • 负责人:
    JONATHAN L TEMTE
  • 依托单位:
CK21-003, Oregon Child Absenteeism due to Respiratory Disease Study - 3
  • 批准号:
    10468590
  • 项目类别:
  • 资助金额:
    $130.81万
  • 财政年份:
    2021
  • 负责人:
    JONATHAN L TEMTE
  • 依托单位:
CK21-003, Oregon Child Absenteeism due to Respiratory Disease Study - 3
  • 批准号:
    10620797
  • 项目类别:
  • 资助金额:
    $24.18万
  • 财政年份:
    2021
  • 负责人:
    JONATHAN L TEMTE
  • 依托单位:
国内基金
海外基金
SRSF3抑制剂SFI003逆转急性髓系白血病耐药性的功能与机制研究
  • 批准号:
    2026JJ60275
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    邢程
  • 依托单位:
新型溶瘤性HPV治疗性疫苗MATV003的构建和药效学研究
  • 批准号:
    JCZRMS202601746
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于JAK-STAT信号通路研究E003调控URSA的Th17/Treg免疫平衡的分子机制
  • 批准号:
    82360318
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    31.00万元
  • 批准年份:
    2023
  • 负责人:
    章志琴
  • 依托单位:
噬菌体PaoP5编码蛋白Orf003通过FleQ抑制铜绿假单胞菌运动的分子机制研究